Movianto further expands European logistics for DAIICHI SANKYO

Movianto, a logistics company specialised in pharmaceutical and healthcare, has expanded the services for DAIICHI SANKYO EUROPE to three additional countries: Austria, Spain and Great Britain. Furthermore the companies’ existing successful cooperation in France is to be continued. Alongside the storage and distribution of DAIICHI SANKYO’s products, Movianto will also be undertaking diverse specialised services along the supply chain in these countries.

The storage of the pharmaceutical products will take place in the warehouses of Movianto’s subsidiaries from where wholesalers are to be supplied. Alongside the European infrastructure and the certified quality standards in all Movianto locations the IT platform, Movianto Prince, was the decisive factor contributing to DAIICHI SANKYO’s decision to extend its European contract.

DAIICHI SANKYO has been relying on Movianto for their logistics in France for many years now. In France and Great Britain, the logistics service provider will be undertaking services such as the storage and transport as well as the complete Order-to-Cash management – this is order processing from receipt stage to invoicing. In Austria and Spain, Movianto will also be responsible for the distribution of promotional materials for DAIICHI SANKYO.

About Movianto
Movianto provides the pharmaceutical, biotechnology and healthcare industry with innovative logistics and distribution solutions across a network of twelve European countries. Movianto’s 600 international clients, including the world’s ten largest pharmaceutical manufacturers, benefit from a broad range of pharmaceutical logistics services and the variety of distribution models at national, regional and European level. Providing consistently high levels of quality and securing transparency of the supply chain are Movianto’s highest priority. Clients are able to profit from the specialist knowledge offered by more than 1,700 of Movianto’s employees. Movianto is a business unit of Celesio AG. For further information, please visit www.movianto.com


About DAIICHI SANKYO
DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese enterprises, Daiichi and Sankyo. With net sales of nearly € 5.9 billion in fiscal year 2008, DAIICHI SANKYO is one of the world’s 20 leading pharmaceutical companies. The company’s world headquarters is in Tokyo, and its European base is located in Munich. The company’s research activities focus on the areas of cardiovascular diseases, hematology, diabetes, anti-infectives and cancer. Its aim is to develop medications that are "best" in their class or to create new classes of pharmaceutical drugs. For more information, please visit:
www.daiichi-sankyo.eu


Contact
Ottilie Krug, Tel. +49 (0)711 900 597 912 / Fax +49 (0)711 900 597 910
Movianto GmbH, Neckartalstrasse 155, 70376 Stuttgart, Germany
E-Mail: ottilie.krug@movianto.com
Internet: www.movianto.com


Veronika Hoeber, Tel. +49 (0)711 947 67 0 / Fax +49 (0)711 9 47 67 87
Sympra GmbH (GPRA), Stafflenbergstrasse 32, 70184 Stuttgart, Germany
E-Mail: movianto@sympra.de
Internet: www.sympra.de


Toby Brown, Tel. +44-20-7292 8681 / Fax +44-20-7287 2905
Buffalo Communications, 44 Wardour Street, London W1D 6QZ, GB
Email: toby.brown@buffalo.co.uk
Internet: www.buffalo.co.uk